This page shows the latest infertility news and features for those working in and with pharma, biotech and healthcare.
to one in ten women of reproductive age that causes abdominal pain and is associated with infertility. ... Forendo also has a preclinical programme targeting polycystic ovarian syndrome (PCOS), a common condition associated with metabolic disorders,
Complementing these patient- use devices, direct-to-consumer blood testing is gradually emerging too, along with self- administered tests for STIs, infertility and other conditions.
PCOS is the most frequent cause of female infertility, affecting somewhere between 5% and 10% of all women and accounting for up to 83% of infertility or pregnancy complications. ... At the moment, PCOS is typically treated with the contraceptive pill to
Titled #Scream4IVF, the campaign features screaming faces of patients who have been affected by infertility. ... But these screams of infertility are not being heard. This suffering is in silence.”.
Rasha Kelej, chief executive officer of Merck Foundation, said: “The prevalence of infertility is so high in Africa, and 85% of cases are due to untreated infectious disease, which can be ... The campaign will also encourage men to talk about
ectopic pregnancy and infertility, as well as an increased risk of HIV.
More from news
Approximately 1 fully matching, plus 37 partially matching documents found.
of infertility, miscarriages and developmental disorders, and could eventually lead to therapeutic applications of stem cells.
As an example of controlled entrepreneurship he cites an Argentinian infertility deal that, in order to meet the specific needs of that market, saw Ferring's general manager bolster its offering
Published: 05 Dec 2010. Client:RESOLVE: The National Infertility Association. Agency:Spectrum. Campaign:The Destination: Family. ... In 2009, Spectrum was tasked with developing a public service announcement and targeted media outreach campaign on the
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Infertility specialist OvaScience has appointed Harald Stock, CEO of German pharma firm Grünenthal, to its board of directors.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
She also has an MSc in reproductive and developmental medicine from the University of Sheffield, and on completion of this was awarded the Infertility Research Trust Prize for achieving the highest
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...